肺癌术后放疗中肺剂量与死亡风险的关联:分层分组法研究
该研究分析178例接受术后放疗的非小细胞肺癌患者,比较简单分组与分层分组下高、低肺剂量组的生存差异。简单分组未见显著差异,分层分组后低肺剂量组总生存显著更长(5年生存率60.1% vs 35.3%,p=0.039),多因素分析肺剂量仍为总生存的显著预后因素(HR=2.08,p=0.019)。
要点
- 分层分组后低肺剂量组5年生存率显著高于高肺剂量组(60.1% vs 35.3%,p=0.039)。
- 多因素分析显示肺剂量是总生存的显著预后因素(HR=2.08,p=0.019)。
- 简单分组未显示生存差异,提示需控制混杂因素后评估肺剂量效应。
核心结论
- 在具有相同混杂因素的非小细胞肺癌术后放疗患者中,肺剂量与死亡风险相关。
研究设计与样本
- 回顾性分析178例接受术后放疗的非小细胞肺癌患者,计算平均肺剂量。
- 采用两种分组方法:按全体患者中位肺剂量简单分组;按各同混杂因素亚组中位肺剂量分层分组。
主要发现
- 简单分组中高、低肺剂量组生存无显著差异。
- 分层分组后低肺剂量组总生存显著长于高肺剂量组(5年生存率60.1% vs 35.3%,p=0.039)。
- 多因素分析中肺剂量仍为总生存的显著预后因素(HR=2.08,p=0.019)。
临床怎么用
- 术后放疗计划评估时应关注肺剂量,分层分析提示其与死亡风险相关。
- 需进一步研究依据肺剂量评估死亡风险,以实施更精准的个体化术后放疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Postoperative radiation therapy may have a detrimental effect on survival in patients with non-small cell lung cancer. We investigated the association of the lung radiation dose with the risk of death in patients treated with postoperative radiation therapy. METHODS: We analyzed 178 patients with non-small cell lung cancer who received postoperative radiation therapy. The mean lung dose was calculated from dose-volume data, and we categorized patients into the high and low lung dose groups using 2 different methods; (1) simple grouping using the median lung dose of all patients, and (2) stratified grouping using the median lung dose of each subgroup sharing the same confounders. We compared clinical variables, and survival between the high and low lung dose groups. RESULTS: In the simple grouping, there were no significant differences in survivals between the high and low lung dose groups. After stratification, the overall survival of low lung dose group was significantly longer than that of high lung dose group (5-year survival, 60.1% vs. 35.3%, p = 0.039). On multivariable analyses, the lung dose remained a significant prognostic factor for overall survival (hazard ratio, HR = 2.08, p = 0.019). CONCLUSIONS: The lung dose was associated with the risk of death in patients with non-small cell lung cancer having the same confounders. Further studies evaluating the risk of death according to the lung dose will be helpful to administer more precise and individualized postoperative radiation therapy.
引用
- Heo J, Noh OK, Kim HI, et al. Lung dose and the potential risk of death in postoperative radiation therapy for non-small cell lung cancer: A study using the method of stratified grouping. Radiother Oncol. 2018. PMID: 29681411. doi:10.1016/j.radonc.2018.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。